MetaCap

DaVita (DVA) vs Mangoceuticals (MGRX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

DaVita is the larger company by market cap ($10.13 billion vs $2.7 million), about 3687.3 times the size. DaVita converts more of its revenue into profit, with a net margin of 5.5% versus -4526.8%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DVA-8.91%MGRX-72.14%
+14%-31%-76%
Oct 7, 20261 yearNov 20, 2026
DVA-10.16%MGRX-70.71%
+11%-32%-75%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DVA versus MGRX key metrics
MetricDVAMGRX
Share price$161.03$0.1236
Market cap$10.13B$2.75M
1-day change+3.00%-7.55%
YTD return+41.74%—
1-year return+33.91%—
5-year return+65.52%—
P/E ratio (TTM)12.19—
Forward P/E9.52—
EPS (TTM)$13.21$-0.52
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$13.64B$456.02K
Revenue growth (YoY)+6.46%-25.96%
Net income (latest FY)$746.80M$-20.64M
Gross margin—54.91%
Operating margin14.98%-3954.28%
Net margin5.47%-4526.76%
52-week high$247.49$1.38
52-week low$101.00$0.121
Distance from 52-week high-34.93%-91.04%
Analyst consensusbuy—
Avg. price target upside+38.04%—
Average volume738.70K638.90K
Shares outstanding62.90M22.22M
Employees78,0003
SectorHealth CareHealth Care
IndustryMisc Health and Biotechnology ServicesMisc Health and Biotechnology Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • DaVita is about 3687.3 times larger than Mangoceuticals by market value ($10.13B vs $2.75M).
  • DaVita is more profitable, keeping 5.5 cents of every revenue dollar as net income versus -4526.8 cents for Mangoceuticals.
  • DaVita grew revenue faster in its latest fiscal year (+6.46% vs -25.96%).

About DaVita

DVA stock →

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.

Health Care · Misc Health and Biotechnology Services · 78,000 employees

About Mangoceuticals

MGRX stock →

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States.

Health Care · Misc Health and Biotechnology Services · 3 employees

DVA vs MGRX FAQ

Which is bigger, DaVita or Mangoceuticals?

DaVita (DVA) is larger, with a market capitalization of $10.13B compared with $2.75M for Mangoceuticals (MGRX).

Are DaVita and Mangoceuticals in the same industry?

Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.

More comparisons